{"data":[{"accessionNo":"0002012383-26-002837","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0001393434","issuerName":"OCULAR THERAPEUTIX, INC","ticker":"OCUL","cusip":"67576A100","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"BlackRock, Inc.","reportingCik":null,"personType":"HC","sharesOwned":15227768,"percentOfClass":7,"filedAt":"2026-07-29","canonicalUrl":"https://xoomar.com/markets/stocks/ocul"},{"accessionNo":"0001172661-26-002031","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001393434","issuerName":"Ocular Therapeutix, Inc","ticker":"OCUL","cusip":"67576A100","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-03-31","reportingPerson":"Deep Track Capital, LP","reportingCik":null,"personType":"IA,OO","sharesOwned":20850000,"percentOfClass":9.53,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/ocul"},{"accessionNo":"0001172661-26-002031","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001393434","issuerName":"Ocular Therapeutix, Inc","ticker":"OCUL","cusip":"67576A100","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-03-31","reportingPerson":"David Kroin","reportingCik":null,"personType":"HC,IN","sharesOwned":20850000,"percentOfClass":9.53,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/ocul"},{"accessionNo":"0001172661-26-002031","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001393434","issuerName":"Ocular Therapeutix, Inc","ticker":"OCUL","cusip":"67576A100","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-03-31","reportingPerson":"Deep Track Biotechnology Master Fund, Ltd.","reportingCik":null,"personType":"CO","sharesOwned":20850000,"percentOfClass":9.53,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/ocul"},{"accessionNo":"0000102909-26-001958","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001393434","issuerName":"Ocular Therapeutix Inc","ticker":"OCUL","cusip":"67576A100","securityClass":"Common Stock","eventDate":"2026-03-13","reportingPerson":"The Vanguard Group","reportingCik":null,"personType":"IA","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-03-27","canonicalUrl":"https://xoomar.com/markets/stocks/ocul"},{"accessionNo":"0001738048-26-000024","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001393434","issuerName":"Ocular Therapeutix Inc","ticker":"OCUL","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-12-31","reportingPerson":"Nimish Shah","reportingCik":null,"personType":"IN","sharesOwned":6862972,"percentOfClass":3.2,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/ocul"},{"accessionNo":"0001738048-26-000024","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001393434","issuerName":"Ocular Therapeutix Inc","ticker":"OCUL","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-12-31","reportingPerson":"Bong Y. Koh","reportingCik":null,"personType":"IN","sharesOwned":6862972,"percentOfClass":3.2,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/ocul"},{"accessionNo":"0001738048-26-000024","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001393434","issuerName":"Ocular Therapeutix Inc","ticker":"OCUL","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-12-31","reportingPerson":"Venrock Healthcare Capital Partners EG, L.P.","reportingCik":null,"personType":"PN","sharesOwned":6862972,"percentOfClass":3.2,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/ocul"},{"accessionNo":"0001738048-26-000024","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001393434","issuerName":"Ocular Therapeutix Inc","ticker":"OCUL","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-12-31","reportingPerson":"Venrock Healthcare Capital Partners III, L.P.","reportingCik":null,"personType":"PN","sharesOwned":6862972,"percentOfClass":3.2,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/ocul"},{"accessionNo":"0001738048-26-000024","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001393434","issuerName":"Ocular Therapeutix Inc","ticker":"OCUL","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-12-31","reportingPerson":"VHCP Co-Investment Holdings III, LLC","reportingCik":null,"personType":"OO","sharesOwned":6862972,"percentOfClass":3.2,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/ocul"},{"accessionNo":"0001738048-26-000024","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001393434","issuerName":"Ocular Therapeutix Inc","ticker":"OCUL","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-12-31","reportingPerson":"VHCP Management III, LLC","reportingCik":null,"personType":"OO","sharesOwned":6862972,"percentOfClass":3.2,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/ocul"},{"accessionNo":"0001738048-26-000024","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001393434","issuerName":"Ocular Therapeutix Inc","ticker":"OCUL","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-12-31","reportingPerson":"VHCP Management EG, LLC","reportingCik":null,"personType":"OO","sharesOwned":6862972,"percentOfClass":3.2,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/ocul"},{"accessionNo":"0001172661-26-000581","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001393434","issuerName":"Ocular Therapeutix, Inc","ticker":"OCUL","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-02-05","reportingPerson":"Deep Track Capital, LP","reportingCik":null,"personType":"IA,OO","sharesOwned":11234132,"percentOfClass":5.13,"filedAt":"2026-02-10","canonicalUrl":"https://xoomar.com/markets/stocks/ocul"},{"accessionNo":"0001172661-26-000581","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001393434","issuerName":"Ocular Therapeutix, Inc","ticker":"OCUL","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-02-05","reportingPerson":"Deep Track Biotechnology Master Fund, Ltd.","reportingCik":null,"personType":"CO","sharesOwned":11234132,"percentOfClass":5.13,"filedAt":"2026-02-10","canonicalUrl":"https://xoomar.com/markets/stocks/ocul"},{"accessionNo":"0001172661-26-000581","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001393434","issuerName":"Ocular Therapeutix, Inc","ticker":"OCUL","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-02-05","reportingPerson":"David Kroin","reportingCik":null,"personType":"HC,IN","sharesOwned":11234132,"percentOfClass":5.13,"filedAt":"2026-02-10","canonicalUrl":"https://xoomar.com/markets/stocks/ocul"},{"accessionNo":"0001172661-26-000554","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001393434","issuerName":"Ocular Therapeutix, Inc","ticker":"OCUL","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-12-31","reportingPerson":"Deep Track Biotechnology Master Fund, Ltd.","reportingCik":null,"personType":"CO","sharesOwned":9234132,"percentOfClass":4.31,"filedAt":"2026-02-10","canonicalUrl":"https://xoomar.com/markets/stocks/ocul"},{"accessionNo":"0001172661-26-000554","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001393434","issuerName":"Ocular Therapeutix, Inc","ticker":"OCUL","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-12-31","reportingPerson":"Deep Track Capital, LP","reportingCik":null,"personType":"IA,OO","sharesOwned":9234132,"percentOfClass":4.31,"filedAt":"2026-02-10","canonicalUrl":"https://xoomar.com/markets/stocks/ocul"},{"accessionNo":"0001172661-26-000554","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001393434","issuerName":"Ocular Therapeutix, Inc","ticker":"OCUL","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-12-31","reportingPerson":"David Kroin","reportingCik":null,"personType":"HC,IN","sharesOwned":9234132,"percentOfClass":4.31,"filedAt":"2026-02-10","canonicalUrl":"https://xoomar.com/markets/stocks/ocul"},{"accessionNo":"0001437749-25-037200","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001393434","issuerName":"OCULAR THERAPEUTIX, INC","ticker":"OCUL","cusip":null,"securityClass":"Common stock (\"Common Shares\")","eventDate":"2025-12-04","reportingPerson":"SUMMER ROAD LLC","reportingCik":null,"personType":"OO","sharesOwned":12134357,"percentOfClass":5.7,"filedAt":"2025-12-08","canonicalUrl":"https://xoomar.com/markets/stocks/ocul"},{"accessionNo":"0001738048-25-000020","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001393434","issuerName":"Ocular Therapeutix Inc","ticker":"OCUL","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-09-30","reportingPerson":"VHCP Management III, LLC","reportingCik":null,"personType":"OO","sharesOwned":12913420,"percentOfClass":7.3,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/ocul"},{"accessionNo":"0001738048-25-000020","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001393434","issuerName":"Ocular Therapeutix Inc","ticker":"OCUL","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-09-30","reportingPerson":"Venrock Healthcare Capital Partners III, L.P.","reportingCik":null,"personType":"PN","sharesOwned":12913420,"percentOfClass":7.3,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/ocul"},{"accessionNo":"0001738048-25-000020","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001393434","issuerName":"Ocular Therapeutix Inc","ticker":"OCUL","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-09-30","reportingPerson":"VHCP Co-Investment Holdings III, LLC","reportingCik":null,"personType":"OO","sharesOwned":12913420,"percentOfClass":7.3,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/ocul"},{"accessionNo":"0001738048-25-000020","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001393434","issuerName":"Ocular Therapeutix Inc","ticker":"OCUL","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-09-30","reportingPerson":"Venrock Healthcare Capital Partners EG, L.P.","reportingCik":null,"personType":"PN","sharesOwned":12913420,"percentOfClass":7.3,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/ocul"},{"accessionNo":"0001738048-25-000020","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001393434","issuerName":"Ocular Therapeutix Inc","ticker":"OCUL","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-09-30","reportingPerson":"VHCP Management EG, LLC","reportingCik":null,"personType":"OO","sharesOwned":12913420,"percentOfClass":7.3,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/ocul"},{"accessionNo":"0001738048-25-000020","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001393434","issuerName":"Ocular Therapeutix Inc","ticker":"OCUL","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-09-30","reportingPerson":"Nimish Shah","reportingCik":null,"personType":"IN","sharesOwned":12913420,"percentOfClass":7.3,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/ocul"},{"accessionNo":"0001738048-25-000020","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001393434","issuerName":"Ocular Therapeutix Inc","ticker":"OCUL","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-09-30","reportingPerson":"Bong Y. Koh","reportingCik":null,"personType":"IN","sharesOwned":12913420,"percentOfClass":7.3,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/ocul"},{"accessionNo":"0001172661-25-004831","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001393434","issuerName":"Ocular Therapeutix, Inc","ticker":"OCUL","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-09-30","reportingPerson":"Deep Track Biotechnology Master Fund, Ltd.","reportingCik":null,"personType":"CO","sharesOwned":13095855,"percentOfClass":6.18,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/ocul"},{"accessionNo":"0001172661-25-004831","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001393434","issuerName":"Ocular Therapeutix, Inc","ticker":"OCUL","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-09-30","reportingPerson":"David Kroin","reportingCik":null,"personType":"HC,IN","sharesOwned":13095855,"percentOfClass":6.18,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/ocul"},{"accessionNo":"0001172661-25-004831","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001393434","issuerName":"Ocular Therapeutix, Inc","ticker":"OCUL","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-09-30","reportingPerson":"Deep Track Capital, LP","reportingCik":null,"personType":"IA,OO","sharesOwned":13095855,"percentOfClass":6.18,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/ocul"},{"accessionNo":"0000315066-25-002779","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001393434","issuerName":"OCULAR THERAPEUTIX INC","ticker":"OCUL","cusip":null,"securityClass":"COMMON STOCK","eventDate":"2025-09-30","reportingPerson":"FMR LLC","reportingCik":null,"personType":"HC","sharesOwned":31785633.58,"percentOfClass":15,"filedAt":"2025-11-05","canonicalUrl":"https://xoomar.com/markets/stocks/ocul"},{"accessionNo":"0000315066-25-002779","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001393434","issuerName":"OCULAR THERAPEUTIX INC","ticker":"OCUL","cusip":null,"securityClass":"COMMON STOCK","eventDate":"2025-09-30","reportingPerson":"Abigail P. Johnson","reportingCik":null,"personType":"IN","sharesOwned":31785633.58,"percentOfClass":15,"filedAt":"2025-11-05","canonicalUrl":"https://xoomar.com/markets/stocks/ocul"},{"accessionNo":"0002012383-25-002681","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001393434","issuerName":"OCULAR THERAPEUTIX, INC","ticker":"OCUL","cusip":null,"securityClass":"Common Stock","eventDate":"2025-09-30","reportingPerson":"BlackRock, Inc.","reportingCik":null,"personType":"HC","sharesOwned":10170232,"percentOfClass":5.8,"filedAt":"2025-10-17","canonicalUrl":"https://xoomar.com/markets/stocks/ocul"}],"updatedAt":"2026-11-05T13:30:46.402Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/ocul","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}